To bring increased attention to the tuberculosis-HIV crisis, Stop TB Partnership, in conjunction with ACTION and the World Health Organization’s TB/HIV Working Group, has put together a TB-HIV Roadmap of events. Many sessions take place in the Global Village or TB-HIV Networking Zone, both of which are areas of the IAC that are free and open to the public, and most events happening in these spaces do not require registration. ACTION will also be hosting an informational booth in the conference’s Global Village - Booth #652. Please come by to meet the team and learn more about ACTION’s global health advocacy partnership.
Tuberculosis (TB) kills one in four people with HIV. One-third of the more than 33 million people with HIV/AIDS are co-infected with TB. Africa has been particularly hard-hit by the co-epidemic: 80 percent of those co-infected with TB and HIV/AIDS live in sub-Saharan Africa. As many as one-third, and in some countries half, of AIDS deaths in sub-Saharan Africa are due to TB.
ACTION is hosting a number of sessions on the TB-HIV co-epidemic, including ones on the importance of the Global Fund for HIV, Tuberculosis and Malaria, and the growing need for investment in research and development for improved TB drugs, vaccines, and diagnostics. With the first cases of totally drug resistant, or XXDR TB, reported earlier this year in India, the need for accelerated action to fight TB has never been more urgent. Increased political will and increased investment from the public, private and philanthropic sectors are needed for this to happen. As U.S. and global policymakers’ attention turns to the IAC--and international and domestic HIV/AIDS policy--the moment has never been better to redouble advocacy efforts.